* Acutus Medical Inc AFIB.OQ AFIB.O is expected to report
results on May 12.
* The Carlsbad, California-based company is expected to report
revenue of $2.775 million, according to the mean estimate from 5
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Acutus Medical Inc is
for a loss of 81 cents per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 1 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 1.1% in the last three months.
* Wall Street's median 12-month price target for Acutus Medical
Inc is $23, about 49.3% above its last closing price
of $11.65.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Dec. 31 2020 -0.74 -0.72 -1.05 Missed -45.4
Sep. 30 2020 -1.06 -0.99 -1.95 Missed -96.6
Jun. 30 2020 -1.03 -1.03 -32.24 Missed -3,030
.1
This summary was machine generated May 10 at 21:38 GMT. All
figures in US dollars unless otherwise stated